Chief Scientific Officer @ (May 2022 - September 2023)
Executive Director of Cancer Research China and Asia @ Eli Lilly (August 2018 - September 2023)
Senior Research Advisor @ Eli Llly and Co. (October 2008 - September 2023)
Senior Biologist @ American Home Product (June 1997 - March 1998)
Xiang Ye Education
The University of Sydney, Australia
Doctor of Philosophy (PhD) (Cell/Cellular and Molecular Biology)
1983-1987
Central China Agriculture University
Bachelor of Science (BS) (Agriculture, General)
1977-1982
Xiang Ye Skills
ADME
Animal Models
Antibodies
Assay Development
Biochemistry
Bioinformatics
Biomarker Discovery
Biomarkers
Biopharmaceuticals
Biotechnology
C Level Management
CRO
Cancer
Cancer Research
Cell
Cell Biology
Chromatography
Clinical Development
Clinical Trials
Drug Design
Drug Development
Drug Discovery
Drug Metabolism
GLP
Genomics
HPLC
High Throughput Screening
IND
Immunology
In Vitro
In Vivo
Infectious Diseases
LC-MS
Lead Change
Lifesciences
Medicinal Chemistry
Molecular Biology
Neuroscience
Oncology
Pharmaceutical Industry
Pharmacodynamics
Pharmacokinetics
Pharmacology
Protein Chemistry
Purification
Signal Transduction
Target Identification
Technology Transfer
Toxicology
Translational Medicine
Vaccines
Lc Ms
Xiang Ye Summary
Xiang Ye, based in Shanghai, CN, is currently a Chief Executive Officer and Chief Scientific Officer at AlphaGen Therapeutics. Xiang Ye brings experience from previous roles at Perpetual Medicines, Risen Pharma, Eli Lilly and Eli Llly and Co.. Xiang Ye holds a 1983 - 1987 Doctor of Philosophy (PhD) in Cell/Cellular and Molecular Biology @ The University of Sydney, Australia. With a robust skill set that includes ADME, Animal Models, Antibodies, Assay Development, Biochemistry and more. Xiang Ye has 1 emails on RocketReach.
Looking for a different Xiang Ye?
Find contact details for 700 million professionals.